E lEvatEd intracranial pressure (ICP) is a common neurosurgical emergency that may arise from several conditions, which cause an intracranial mass effect. 1, 9, 34, 35, 46 In the case of conservatively refractory ICP elevation, the only viable treatment option is ICP-lowering surgery, i.e., decompressive craniectomy (DC), 13 in which a large portion of the skull bone is removed and the dura mater opened, creating more room for the brain tissue to expand and thus reducing the ICP. 44 In our 3 centers, the bone flap removed in DC is customarily kept ABBREVIATIONS BFR = bone flap resorption; CP = cranioplasty; DC = decompressive craniectomy; DM = diabetes mellitus; FiNCIR = Finnish National Cranial Implant Registry; ICP = intracranial pressure; SSI = surgical site infection. RESULTS The cohort comprised 207 patients with a mean follow-up period of 3.7 years (SD 2.7 years). The overall complication rate was 39.6% (82/207), the bone flap removal rate was 19.3% (40/207), and 11 patients (5.3%) died during the follow-up period. Smoking (OR 3.23, 95% CI 1.50-6.95; p = 0.003) and age younger than 45 years (OR 2.29, 95% CI 1.07-4.89; p = 0.032) were found to independently predict subsequent autograft removal, while age younger than 30 years was found to independently predict clinically relevant bone flap resorption (OR 4.59, 95% CI 1.15-18.34; p = 0.03). The interval between craniectomy and cranioplasty was not found to predict either bone flap removal or resorption. CONCLUSIONS In this large, multicenter cohort of patients with autologous cranioplasty, smoking and younger age predicted complications leading to bone flap removal. Very young age predicted bone flap resorption. The authors recommend that physicians extensively inform their patients of the pronounced risks of smoking before cranioplasty.
deep frozen at -70°C until reimplantation during cranioplasty (CP).
The cranium is repaired during CP by returning the previously removed autologous bone flap or by placing an artificial implant in the defect area. A successful CP will restore the contour of the cranium, protect the brain, and ensure a natural ICP, and some patients also show neurological improvement post-CP. 5, 6, 11, 38 Thus, CP has a great potential for improving the patient's quality of life. Although widely regarded as a routine operation, CP often involves serious complications, such as postoperative hemorrhages, surgical site infection (SSI), and, most importantly, resorption of the autologous bone flap. 26, 42, 43 Bone flap resorption (BFR) implies weakening and loosening of the autologous bone flap after reimplantation and is regarded as a late CP complication involving nonunion of the bone flap with the surrounding bone margins and cavity formation in the flap itself, which eventually necessitates removal of the bone flap and a new CP using a synthetic implant. These additional operations increase costs and necessitate further hospital stays, while rendering the patient vulnerable to additional complications. The reported prevalence of BFR with autologous CPs in other settings approximately similar to ours has varied significantly, from 1.4% to 32.0%, 17, 28 with infection rates ranging from 4.6% to 16.4%. 4, 48 In order to carry out a comprehensive investigation into the predictors of CP outcomes, we established a nationwide Finnish National Cranial Implant Registry (FiNCIR), based on a consortium of 5 tertiary-level Finnish university hospitals with neurosurgical centers. These centers are responsible for all major calvarial reconstructive surgery in Finland and treatment of the associated complications. At present, the database contains data from 3 university hospitals covering a total of 481 CPs, and it is projected to cover all of Finland in the future. This paper is the first published work on the FiNCIR study and concentrates on evaluating predictors of outcome of autologous CP and BFR.
Methods

Patients and Selection
In this multicenter study, we identified all patients who had undergone CP at Oulu University Hospital and Turku University Hospital between January 1, 2002, and December 31, 2015, or at Kuopio University Hospital between January 1, 2005, and December 31, 2015. Of a total of 481 operations, we identified 207 primary autologous CPs, which compose the present cohort. Three autologous CPs were nonprimary and were therefore excluded. These 3 tertiary-level university hospitals serve separate districts with a total of 2,456,567 inhabitants as of December 31, 2015 , and are the only hospitals in which CP is performed in these districts. Thus, all patients with CP complications requiring neurosurgical interventions are also referred to these centers. Nonprimary CPs, minor CPs (e.g., small trepanation hole repairs), and CPs for craniosynostoses were excluded from the present material.
The study protocol was approved by the corresponding medical directors of all 3 hospitals. Additional ethics board approval was not required for this retrospective study in which data were extracted solely from patient databases, and patients were not contacted.
Management of Elevated ICP
Trauma patients who have an increased ICP greater than 20 mm Hg regardless of conservative treatment are candidates for DC if a good neurological outcome can be expected. For stroke patients, the choice of surgical approach is based more subjectively on the patient's clinical condition, the findings on a CT scan, and the intraoperative decision of the surgeon. Some tumors may also require DC and subsequent CP. All 3 hospitals follow the international protocol for the treatment of elevated ICP.
At all centers, the standard protocol for therapeutic management of ICP aims to maintain an ICP of less than 20 mm Hg and a cerebral perfusion pressure of greater than 60 mm Hg by applying treatments in a stepwise scheme. All patients with a Glasgow Coma Scale score less than 8 undergo placement of an intraparenchymal ICP monitoring probe on a standard basis. If ICP remains more than 20 mm Hg despite maximal medical therapy and insertion of a possible ventriculostomy, a large unilateral frontotemporoparietal DC (hemicraniectomy) or a bifrontal DC is performed based on the neurosurgeon's decision.
Clinical Data
Clinical data on patient characteristics, lifestyle, diabetes mellitus (DM), the etiology of the DC (i.e., primary diagnosis), the time interval between the DC and CP operations, complications, and possible implant removal were extracted from the hospital records. Complications recorded were BFR, deep and superficial SSIs, hematoma and seroma, CSF leak, unsatisfactory cosmesis, implant migration, hydrocephalus, and exposure of implant. All patients underwent one or more CPs, but only the primary autologous CPs were recorded here. Patients were considered obese if their BMI exceeded 30 kg/m 2 , in accordance with the WHO criteria. 49 Data on smoking and alcohol or other intoxicant abuse were also collected; a patient was considered to be a nonsmoker and nonabuser of intoxicants unless specifically mentioned as such in the hospital records. The size of the bone flap was determined from perioperative CT scans using the lateral 2D scout image. The CP groups with primary diagnoses of nontraumatic intracranial hemorrhage, intracranial ischemia, or nontraumatic subarachnoid hemorrhage were combined into a single stroke group. Data on the deaths of CP patients were acquired from Statistics Finland.
Outcome Measures
The primary end point was all-cause autologous bone flap removal. All patients underwent follow-up from the CP operation until bone flap removal, death, or December 31, 2015. The CP outcome was classified as autograft survival or all-cause bone flap removal as of the last followup date. A subgroup analysis was performed for patients with clinical BFR; outcomes were divided into nonresorbed bone flap versus CP removal or refixation due to BFR. The time from CP to BFR was calculated as the time between the CP and the head CT scan that confirmed the presence of BFR, except for one patient, whose BFR was discovered during a wound revision procedure, and so the date of CP removal was used instead of the CT scan date. The complications recorded were clinical BFR, deep and superficial SSI, hematoma, seroma, CSF leak, hydrocephalus, implant exposure, implant breakage, implant migration, and unsatisfactory cosmesis.
Statistical Analysis
All statistical analyses were performed using IBM SPSS (version 22, IBM Corp.). Categorical variables were first compared using Pearson's chi-square test or Fisher's exact test and the means of the continuous variables with ANOVA. Variables that were of clinical importance and/ or statistically significant in Pearson's chi-square test, Fisher's exact test, or ANOVA were chosen for further logistic regression analysis. Odds ratios and 95% confidence intervals of these variables were determined using binary logistic regression analysis with the enter method. Variables included in the logistic regression analyses were sex, smoking, intoxicant abuse, age, DM, and time interval between DC and CP (0-3 months, 3-6 months, or > 6 months). Age was classified as either over/under the median (44 years) or 0-29, 30-50, or older than 50 years at the time of CP. The latter cutoff values were applied in order to facilitate interstudy comparison, as similar cutoffs have been used in previous publications.
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A 2-tailed p value of < 0.05 was considered statistically significant. Follow-up times, calculated as the time between the CP and removal of the bone flap, death, or December 31, 2015, are reported as the mean with SD. Likewise, time intervals between DC and CP are reported as mean with SD.
Results
Descriptive Data
The baseline characteristics and outcomes of the 207 autologous CP patients that we identified are shown in Tables 1 and 2 . The mean follow-up time was 3.7 years (SD 2.7 years, range 2 days to 11.9 years). Stroke was the most common etiology of bone defect, accounting for 111 (53.6%) cases, while 77 (37.2%) defects had a traumatic etiology. The mean time interval between DC and CP was 184 days (SD 286 days), and a total of 82 (39.6%) autologous CPs resulted in one or more complications, leading in ). Twenty-three (57.5%) of the graft removals occurred during the first 6 postoperative months, 1 (2.5%) between 6 and 12 months, and 16 (40.0%) occurred later than 12 months postoperatively. Eleven patients (5.3%) had died during the follow-up period.
Cranioplasty Outcomes: Normal Recovery Versus All-Cause Autograft Removal
Postoperative complications and complications that required bone flap removal are listed in Table 3 . The results of the logistic regression analysis of the 40 cases in which the autograft was subsequently removed are shown in Table 4 . Cigarette-smoking patients were more likely to undergo subsequent bone flap removal after CP than nonsmokers in a model adjusted for age, while in the same model an age less than 45 years at the time of CP was a risk factor for bone flap removal. In an interaction analysis, no significant impact of interaction between these 2 variables was observed (OR 0.54, 95% CI 0.11-2.70; p = 0.45). Interestingly, smokers also had post-CP SSIs significantly more often than nonsmokers (20.9% vs 7.3%, p = 0.02).
Patients with DM had a slight tendency for an increased risk of bone flap removal (40.0% vs 18.8%; OR 5.64, 95% CI 0.81-39.38; p = 0.08) when adjusted for smoking, sex, and age (over/under the median), but statistical significance was not reached. When compared to all other etiologies and adjusted by smoking, sex, and age (over/under the median), neither trauma (OR 1.24, 95% CI 0.57-2.69; p = 0.59) nor stroke (OR 0.91, 95% CI 0.43-1.93; p = 0.81) had a significant impact on the CP outcome. Similarly, the timing of CP had no statistically significant impact on the outcome in a model adjusted for sex and age (Table 5 ).
Subgroup Analyses: Bone Flap Survival Versus Bone Flap Resorption
Nineteen (9.2%) of the 207 autologous CPs developed clinical BFR, which necessitated implant refixation or removal at a later time. BFR occurred after a mean interval of 534.1 days (SD 397.4 days, range 103-1742 days). In a model adjusted for sex, patients younger than 30 years at the time of CP had a significantly higher risk of develop- ing BFR than those older than 50 years (Table 6) , and in the same model those 30-50 years at the time of CP were found to have a higher odds ratio for BFR than those older than 50 years, although the latter was not a statistically significant finding.
In the model adjusted for sex and age, a shorter time interval between DC and CP was found to be a risk factor for BFR (Table 5) , although the correlation seemed to be very slight. Smoking had no significant effect on the development of BFR when adjusted for age over/under the median (OR 1.70, 95% CI 0.60-4.84; p = 0.32), and the size of the bone defect was not found to predict subsequent BFR independently on adjustment for age (over/ under the median) and sex (OR 1.01, 95% CI 1.00-1.02; p = 0.16). Compared to all other etiologies, stroke (OR 0.66, 95% CI 0.23-1.83; p = 0.42) or trauma (OR 1.66, 95% CI 0.59-4.62; p = 0.34) did not have any significant effect on the development of BFR after adjustment for smoking, sex, and age (over/under the median). The 2D bone flap area was not found to have a statistically significant effect on BFR (Table 2) .
Discussion
Main Results
The main finding in the present cohort of patients with autologous CP was that cigarette smoking is an independent predictor of a poor CP outcome, leading to autograft removal, while young age was found to be a risk factor for both CP removal and BFR. The time interval from DC to CP did not affect the risk of CP removal or BFR, and the primary diagnosis was not found to affect the CP outcome.
Most DC patients require long-term intensive care and are unable to smoke, but in our experience, many of them continue smoking after recovery from the primary insult, possibly compromising the CP outcome. The mechanism of smoking to the CP outcome is likely mediated by the vasoconstriction caused by nicotine 41 and lowered tissue oxygen, 14 which, through surgical site oxygen deprivation, expose the patient to complications that possibly require bone flap removal. Indeed, we found that in our patient population, smokers had surgical site infections significantly more often than nonsmoking patients. Therefore, physicians should inform their patients of the pronounced risks of smoking before CP.
The negative effect of smoking on the CP outcome is consistent with that found in existing reports on the association between smoking and adverse surgical outcomes in both neurosurgery 20 and other surgical specialties. 16, 15 On the other hand, preoperative abstinence from smoking has been shown to provide protection from adverse surgical outcomes in numerous fields of surgery, 19, 23, 27 and the prospect of major surgery may boost patients' motivation to cease smoking. 39 It is possible, however, that even former smoking habits could have a negative effect on the CP outcome compared with complete abstinence from smoking.
Aseptic BFR is a late complication, and it has been well demonstrated that younger age increases the risk of BFR. 7, 12, 18, 26, 33, 36, 37 Most skull growth takes place during the 1st year of life, but growth proceeds until the cranial vault is fully formed in adulthood. Cranial growth includes resorptive activity, and the preadolescent skull bone may be metabolically more active than the adult skull in this respect, which could play a part in the higher BFR prevalence observed in young patients.
We hypothesized that CPs performed later would be more susceptible to complications due to a longer storage time, as cryopreservation likely sacrifices the majority of the cells in the bone flap 32 or renders them nonviable. 2 Thus, the bone flap is considered a nonvital autologous scaffold, but it is hoped that it will integrate with the adjacent vital bone. In all 3 hospitals in this study, the bone flaps were deep frozen to -70°C immediately after DC and thawed for CP. We did not find any clear effect of CP timing on the outcome with this protocol. In keeping with this, a recent meta-analysis of 25 papers by Malcolm et al. 25 concluded only that early any-material CPs were associated with increased odds ratios for hydrocephalus, and no association was found between CP timing and other complications, indicating that, regarding complications, the timing of CP might not be as important as previously hypothesized. The primary end point in the present study, however, was implant removal rather than any particular complication.
Although BFR resembles the physicochemical reaction of dissolution of bone matrix hydroxyapatite and enzymatic degradation of bone collagen, osteoclastic dissolution of the inorganic matrix of the bone flap should, in principle, which should inhibit osteoclastic activity. 15, 24 Therefore, the primary mechanism of BFR more likely resembles avascular necrosis rather than direct bone resorption by osteoclastic activity or enzymatic degradation of the collagenous matrix. Still, it remains unclear which factors result in clinically relevant BFR in CP patients.
Due to the known negative effects of DM on surgical outcomes 8, 21, 31, 50 and the global increase in the prevalence of both type I and type II DM, 30 the disease is likely to become an increasingly important variable in surgical decision-making in the future. We did not find a statistically significant association between DM and bone flap removal, but diabetic patients seemed to have a tendency for an increased risk of bone flap removal. The present sample size was nevertheless insufficient to clarify this matter definitively, since the cohort included only 5 diabetic patients, among whom the CP was removed in 2 cases.
Our findings suggest that the etiology of the ICP elevation (e.g., trauma, stroke) is not an important factor affecting bone flap survival. All of these etiologies cause brain damage, but only those with good recovery from the primary insult are selected for CP. This explains why no differences were observed between the primary diagnosis groups.
Strengths and Weaknesses
The strengths of this study include a relatively large patient population in a multicenter setting. The cohort was large enough in size to demonstrate the most important factors affecting the outcome of CP, and the follow-up period was relatively long. The overall complication and CP removal rates in our patients were 39.6% and 19.3%, respectively, both of which are consistent with the figures reported in the current literature. 3, 10, 22, 29, 37, 43, 47 The patient series presented here was nonselected, as it comprised all CP patients from the 3 hospital districts-all of the districts' CPs were performed in these hospitals, and all patients with postoperative complications were referred to one of the 3 centers. Thus, no patients or complications were lost for follow-up, which is not the case in most hospital-based series. This might have slightly increased the prevalence of complications and the percentage of patients requiring bone flap removal.
The best method for studying surgical outcomes is a controlled prospective trial, but this is impossible to arrange in the case of CP for ethical reasons. All of our patients had indications for CP, and they were not randomizable in terms of reconstruction. Even with this multicenter setting, it would take more than 10 years to gather a population as large as this one, and treatment protocols could change over such a period, which they did not during the period studied here. It is still a possibility that the hospitals may have differed in their treatment protocols and that this may have affected the outcomes. The weakness of using lateral 2D scout images in evaluating the bone flap size is the underestimation caused by the skull curvature, especially near the vertex. Also, most CPs in Finland are performed in patients younger than 65 years, which may have skewed the results somewhat.
Conclusions
Cranioplasty is associated with a notable burden of postoperative complications and subsequent reoperations. This large, multicenter series demonstrated an increased risk of complications leading to autologous CP removal among cigarette-smoking patients and patients younger than 45 years. We recommend that physicians extensively inform their patients on the pronounced risks of smoking before CP. Patients younger than 30 years had a significantly increased risk of BFR, leading to flap removal or reoperation. The role of DM as a risk factor for a poor CP outcome requires further evaluation, as the worldwide prevalence of diabetes is on the rise.
